The role of CEO is, subordinate to the Board of Directors and its main task is to carry out the daily management of Xbrane and the daily activities of the Company. The Board of Director’s rules of procedure and instructions for the CEO stipulate for which matters the Board of Directors is responsible to decide upon, and which decisions fall within the CEO’s area of responsibility. The CEO is also responsible for producing reports and necessary data for decision-making ahead of Board meetings and for presenting the material at Board meetings.

Xbrane has a management team consisting of six people, which in addition to the CEO/Head of Investor Relations is comprised of the CFO, COO/Head of Biosimilars, COO/Head of Long-acting injectables, CTO and Head of Clinical affairs.

Name Position Member of the senior management since Employed at the Company since Holdings in Xbrane
Shares Warrants Convertibles
Martin Åmark CEO/Head of Investor Relations 2015 2015 152,896 24,000
Susanna Helgesen CFO 2017 2017 12,136 24,000
Siavash Bashiri COO/Head of Biosimilars 2012 2012 102,175 7,000
Paolo Sarmientos COO/Head of Long-acting injectables 2015 2015 296,939 74,054
David Vikström CTO 2014 2014 32,055 24,000
Dina Jurman Head of Clinical affairs 2017 2017 420